Physician profile
Lee E Ponsky
NPI 1871511972
$1,252.56
in general payments reported to CMS, 2019-2025
13 companies · $234 in 2025
The $234 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $209 · 2020: $347 · 2021: $168 · 2022: $54.02 · 2023: $205 · 2024: $35.66 · 2025: $234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $474.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $228.86 | 2019-2023 | Ams 700 |
| Rochester Medical Corporation | $202.20 | 2021-2022 | |
| Dentsply Ih INC. | $176.88 | 2020 | |
| Coloplast Corp | $137.61 | 2025 | |
| Baxter Healthcare | $103.25 | 2020 | |
| Calyxo, INC. | $96.64 | 2025 | Cvac Aspiration System |
| C. R. Bard, INC. & Subsidiaries | $85.13 | 2023 | Bard Urinary Drainage Bag |
| Medtronic USA, INC. | $77.06 | 2019 | |
| Neotract INC. | $49.25 | 2020 | |
| Teleflex LLC | $35.66 | 2024 | Urolift |
| Allergan, INC. | $22.38 | 2019 | |
| Photocure INC | $19.96 | 2022 | |
| Zyla Life Sciences, INC. | $17.68 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lee Ponsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.